KA
Kriti Amol Pathrikar
About Kriti Amol Pathrikar
Data last updated:
Kriti Amol Pathrikar is a Director at Simaar Samarth Ivf Private Limited (since 2022), Director at Embrogen Embryology Private Limited (since 2022) and Director at Ninad Foundation (since 2023). The companies operate in Healthcare and Non-Profit Organizations. The 2 current companies with reported revenue have a combined latest revenue of ₹2.22 Cr; the largest is Simaar Samarth Ivf Private Limited at ₹2.19 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 22 Sep 2022 | 2022 | ₹2.19 Cr (FY 2025) | Active | |
| Director | 01 Sep 2022 | 2022 | ₹2.2 Lakh (FY 2025) | Active | |
| Director | 12 Oct 2023 | 2023 | Active |
Board colleagues of Kriti Amol Pathrikar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Atish Asaramji Ladda | 08248750 | Simaar Samarth Ivf Private Limited | Director |
| Harshlata Atish Laddha | 09745037 | Simaar Samarth Ivf Private Limited | Director |
| Amol Madhukar Pathrikar | 09723552 | Embrogen Embryology Private Limited , Ninad Foundation | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kriti Amol Pathrikar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kriti Amol Pathrikar
Kriti Amol Pathrikar currently holds 3 directorships: Simaar Samarth Ivf Private Limited (Director, since 22 Sep 2022, revenue ₹2.19 Cr (FY 2025)); Embrogen Embryology Private Limited (Director, since 01 Sep 2022, revenue ₹2.2 Lakh (FY 2025)); Ninad Foundation (Director, since 12 Oct 2023).
Kriti Amol Pathrikar was first appointed on 01 Sep 2022 as Director at Embrogen Embryology Private Limited. The most recent appointment on record is 12 Oct 2023 at Ninad Foundation.
The 2 current companies of Kriti Amol Pathrikar that report revenue have a combined latest revenue of ₹2.22 Cr: Simaar Samarth Ivf Private Limited ₹2.19 Cr (FY 2025); Embrogen Embryology Private Limited ₹2.2 Lakh (FY 2025).
The current boards of Kriti Amol Pathrikar's companies include Atish Asaramji Ladda (Simaar Samarth Ivf Private Limited), Harshlata Atish Laddha (Simaar Samarth Ivf Private Limited), Amol Madhukar Pathrikar (Embrogen Embryology Private Limited).